Delaying Amphotericin B-based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis. Chamilos, G., Lewis, R., & Kontoyiannis, D. Clinical Infectious Diseases, 47(4):503–509, 2008. Cited By :487 \par Cited By :487 \par Export Date: 20 November 2022 \par Export Date: 20 November 2022
doi  bibtex   
@article{chamilos.etal_2008c,
  title = {Delaying Amphotericin {{B-based}} Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis},
  author = {Chamilos, G. and Lewis, R.E. and Kontoyiannis, D.P.},
  year = {2008},
  journal = {Clinical Infectious Diseases},
  volume = {47},
  number = {4},
  pages = {503--509},
  doi = {10.1086/590004},
  note = {Cited By :487
\par
Cited By :487
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/SEKWMFNV/Chamilos et al_2008_Delaying amphotericin B-based frontline therapy significantly increases.pdf}
}

Downloads: 0